EssilorLuxottica (ENXTPA:EL) Stock Looks Cheap Relative To Fair Value
EssilorLuxottica Société anonyme has had a weak share price so far this year, yet the valuation checks send mixed messages, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while traditional earnings multiples lean in the opposite direction.
- Year to date the stock is down 38.8%, which puts recent performance under clear pressure and makes the current valuation more important for decision making.
- For a business that depends heavily on consistent eyewear demand and disciplined capital spending, stronger cash flow visibility can support the intrinsic value case, while any sustained pressure on margins or higher financing needs may weigh on what investors are prepared to pay.
- EssilorLuxottica Société anonyme scores 3 out of 6 on our value checks, which points to a mixed picture rather than a clear bargain or clear overvaluation.
The issue now is whether the gap between the intrinsic value estimate and the earnings multiple view offers a sensible margin of safety at the current EssilorLuxottica Société anonyme share price.
Does EssilorLuxottica Société anonyme Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) method estimates what EssilorLuxottica Société anonyme could be worth based on the cash it is expected to generate for shareholders. The model uses a 2 Stage Free Cash Flow to Equity approach that starts from the latest twelve month free cash flow of about €3.7b and then assumes that cash flows continue to grow rather than shrink. This profile fits a mature business with sizeable ongoing investment needs but still meaningful cash generation.
On these projections, the intrinsic value comes out at around €287.77 per share. Compared with the current EssilorLuxottica Société anonyme share price, that implies the stock trades at a 43.5% discount to the DCF estimate and screens as undervalued on this cash flow view.
On the DCF numbers alone, EssilorLuxottica Société anonyme appears undervalued relative to the cash flows analysts expect it to produce.
Our Discounted Cash Flow (DCF) analysis suggests EssilorLuxottica Société anonyme is undervalued by 43.5%. Track this in your watchlist or portfolio, or discover 257 more high quality undervalued stocks.
Does EssilorLuxottica Société anonyme Look Pricey on Earnings?
The P/E ratio suits EssilorLuxottica Société anonyme because earnings are a key lens for how the market prices a mature, profitable business. At the moment the stock trades on a P/E of about 30.0x, which is higher than the Medical Equipment industry average of roughly 24.7x and also below the peer group average of about 38.2x. This indicates the market is paying more for each euro of EssilorLuxottica Société anonyme earnings than for the sector as a whole, although not at the very top end of peer valuations.
A more tailored benchmark that factors in EssilorLuxottica Société anonyme scale, margins and risk profile points to a Fair P/E Ratio of about 24.4x. That is meaningfully below the current 30.0x level. The gap suggests the stock carries a valuation premium that is not fully supported by this fair value framework, even after allowing for its business profile within the medical equipment space.
On the P/E yardstick, EssilorLuxottica Société anonyme currently screens as overvalued relative to what this model would flag as a fair earnings multiple.
See what the numbers say about this price — find out in our valuation breakdown.
The EssilorLuxottica Société anonyme Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for EssilorLuxottica Société anonyme pick up where this valuation puzzle leaves off and spell out what would need to happen to growth, margins and earnings for the stock to be worth materially more or less than today's price, based on scenarios shared on the Community page. Each Narrative ties a specific fair value to a particular set of catalysts and risks, so you can track over time which version of EssilorLuxottica Société anonyme's story is playing out.
One of the top community narratives on EssilorLuxottica Société anonyme: 51% undervalued
"Stellest 2.0 and AI-enabled platforms could become global standards in pediatric vision care and connected eyewear, leading to market dominance..."
Read one of the top narratives on EssilorLuxottica Société anonyme
Do you think there's more to the story for EssilorLuxottica Société anonyme? Head over to our Community to see what others are saying!
The Bottom Line
For EssilorLuxottica Société anonyme, the Discounted Cash Flow (DCF) intrinsic value points to a sizeable discount, while the P/E multiple suggests the stock is overvalued relative to its earnings peers. That split reflects a cash flow story that looks stronger than what current sentiment and sector comparisons imply. The broader checks sit in the middle, so neither signal fully wins the argument. The key question from here is whether EssilorLuxottica Société anonyme can deliver the cash flows implied in the intrinsic value estimate without eroding margins or taking on meaningfully higher funding needs.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com